These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 27308410)
21. Expanding the Biotherapeutics Realm via miR-34a: "Potent Clever Little" Agent in Breast Cancer Therapy. Mohammady M; Ghetmiri SI; Baharizade M; Morowvat MH; Torabi S Curr Pharm Biotechnol; 2019; 20(8):665-673. PubMed ID: 31244419 [TBL] [Abstract][Full Text] [Related]
22. miR-34a Inhibits Cell Proliferation by Targeting SATB2 in Hepatocellular Carcinoma. Wu G; Li Z; Wang Y; Ju X; Huang R Biomed Res Int; 2018; 2018():2863902. PubMed ID: 30627547 [TBL] [Abstract][Full Text] [Related]
23. miR-34a induces cellular senescence via modulation of telomerase activity in human hepatocellular carcinoma by targeting FoxM1/c-Myc pathway. Xu X; Chen W; Miao R; Zhou Y; Wang Z; Zhang L; Wan Y; Dong Y; Qu K; Liu C Oncotarget; 2015 Feb; 6(6):3988-4004. PubMed ID: 25686834 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1. Li XJ; Ji MH; Zhong SL; Zha QB; Xu JJ; Zhao JH; Tang JH Arch Med Res; 2012 Oct; 43(7):514-21. PubMed ID: 23085450 [TBL] [Abstract][Full Text] [Related]
25. Polymeric Hybrid Nanomicelles for Cancer Theranostics: An Efficient and Precise Anticancer Strategy for the Codelivery of Doxorubicin/miR-34a and Magnetic Resonance Imaging. Xie X; Chen Y; Chen Z; Feng Y; Wang J; Li T; Li S; Qin X; Wu C; Zheng C; Zhu J; You F; Liu Y; Yang H ACS Appl Mater Interfaces; 2019 Nov; 11(47):43865-43878. PubMed ID: 31684723 [TBL] [Abstract][Full Text] [Related]
27. Dual biomarkers long non-coding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors. Toraih EA; Alghamdi SA; El-Wazir A; Hosny MM; Hussein MH; Khashana MS; Fawzy MS PLoS One; 2018; 13(10):e0198231. PubMed ID: 30289954 [TBL] [Abstract][Full Text] [Related]
28. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway. Ma Y; Qin H; Cui Y Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44. Yu G; Yao W; Xiao W; Li H; Xu H; Lang B J Exp Clin Cancer Res; 2014 Dec; 33(1):779. PubMed ID: 25551284 [TBL] [Abstract][Full Text] [Related]
30. Anticancer Drug-Induced Epithelial-Mesenchymal Transition via p53/miR-34a axis in A549/ABCA3 Cells. Yamamoto A; Kawami M; Konaka T; Takenaka S; Yumoto R; Takano M J Pharm Pharm Sci; 2019; 22(1):516-524. PubMed ID: 31603744 [TBL] [Abstract][Full Text] [Related]
31. Regulation of Apoptosis by SYB in HepG2 Liver Cancer Cells is Mediated by the P53/Caspase 9 Axis. Sharula ; Wu Z Anticancer Agents Med Chem; 2017; 17(7):941-947. PubMed ID: 28356025 [TBL] [Abstract][Full Text] [Related]
32. ROS-Responsive Polymeric Micelles for Triggered Simultaneous Delivery of PLK1 Inhibitor/miR-34a and Effective Synergistic Therapy in Pancreatic Cancer. Xin X; Lin F; Wang Q; Yin L; Mahato RI ACS Appl Mater Interfaces; 2019 Apr; 11(16):14647-14659. PubMed ID: 30933478 [TBL] [Abstract][Full Text] [Related]
33. 0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop. Xia C; Shui L; Lou G; Ye B; Zhu W; Wang J; Wu S; Xu X; Mao L; Xu W; Chen Z; Liu Y; Zheng M Sci Rep; 2017 Jun; 7(1):4396. PubMed ID: 28667294 [TBL] [Abstract][Full Text] [Related]
34. miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells. Yu G; Li H; Wang J; Gumireddy K; Li A; Yao W; Tang K; Xiao W; Hu J; Xiao H; Lang B; Ye Z; Huang Q; Xu H J Urol; 2014 Oct; 192(4):1229-37. PubMed ID: 24866595 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-34a suppresses aggressiveness of hepatocellular carcinoma by modulating Han R; Chen X; Li Y; Zhang S; Li R; Lu L Cancer Manag Res; 2019; 11():2963-2976. PubMed ID: 31114344 [No Abstract] [Full Text] [Related]
37. Synergy between next generation EGFR tyrosine kinase inhibitors and miR-34a in the inhibition of non-small cell lung cancer. Zhao J; Guerrero A; Kelnar K; Peltier HJ; Bader AG Lung Cancer; 2017 Jun; 108():96-102. PubMed ID: 28625657 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Yang S; Li Y; Gao J; Zhang T; Li S; Luo A; Chen H; Ding F; Wang X; Liu Z Oncogene; 2013 Sep; 32(36):4294-303. PubMed ID: 23001043 [TBL] [Abstract][Full Text] [Related]
39. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p. Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891 [TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA SNHG7 inhibits NLRP3-dependent pyroptosis by targeting the miR-34a/SIRT1 axis in liver cancer. Chen Z; He M; Chen J; Li C; Zhang Q Oncol Lett; 2020 Jul; 20(1):893-901. PubMed ID: 32566017 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]